Molecular Markers in the World Health Organization Classification of Head and Neck Tumors, Fifth Edition
- Amit Agarwal 1, Girish Bathla 1, Alok Bhatt 1, John Murray 1, Dinesh Rao 1, Kanupriya Vijay 1, Patricia Rhyner 1, Prasanna Vibhute 1
- Amit Agarwal 1, Girish Bathla 1, Alok Bhatt 1
- 1From the Departments of Radiology (A.A., A.B., J.M., D.R., P.R.) and Neuroradiology (P.V.), Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224; Department of Radiology, Mayo Clinic, Rochester, Minn (G.B.); and Department of Radiology, UT Southwestern Medical Center, Dallas, Tex (K.V.).
- 0From the Departments of Radiology (A.A., A.B., J.M., D.R., P.R.) and Neuroradiology (P.V.), Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224; Department of Radiology, Mayo Clinic, Rochester, Minn (G.B.); and Department of Radiology, UT Southwestern Medical Center, Dallas, Tex (K.V.).
|
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Recent head and neck tumor classifications incorporate molecular and genetic data, enhancing objectivity. Radiologists must understand these changes for improved tumor interpretation and patient care.
Area Of Science
- Oncology
- Genetics
- Pathology
Background
- Conventional histopathology has limitations in tumor grading and classification.
- Molecular markers and tumor genetics have advanced significantly over the past decade.
- Recent World Health Organization (WHO) classifications incorporate molecular and genetic data.
Purpose Of The Study
- To update radiologists on major changes in the fifth edition of the WHO classification of head and neck tumors (HN5).
- To provide radiologists with a foundational understanding of pathology and genetics relevant to head and neck tumors.
- To highlight molecular alterations and newly classified entities in head and neck tumors.
Main Methods
- Review of molecular and genetic advancements in tumor classification.
- Analysis of changes introduced in the HN5 classification, including additions, deletions, and reclassifications.
- Focus on molecular alterations in epithelial and nonepithelial head and neck tumors.
Main Results
- The HN5 classification integrates molecular markers for more objective and standardized tumor assessment.
- New tumor entities have been recognized and reclassified based on molecular profiles.
- Radiologists are now included in the classification process to integrate imaging findings.
Conclusions
- Understanding molecular and genetic changes is crucial for radiologists to improve tumor interpretation and clinical practice.
- These updated classifications impact therapy decisions, prognosis, and clinical research.
- Radiologists play an integral role in the multidisciplinary team for head and neck tumor management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:07
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:12
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

